Haleon Pakistan Limited, formerly known as GlaxoSmithKline, has approved an investment of £3.58 million (USD 4.9 million) to ...

Haleon Pakistan Limited has approved a £3.58 million investment to expand and modernize its Panadol Liquid packaging line, as ...

The decision follows a high-level review by the subject expert committee for vaccines, which raised an alarm over the safety ...

GSK (GSK) has agreed to buy US-listed biotech RAPT Therapeutics (US: RAPT) for $58 a share, valuing the company at about $2.2bn (£1.6bn), as it bolsters its respiratory and immunology pipeline.

Dhaka, Jan. 7 -- The government has agreed in principle to bring profitable state-owned enterprises, including multinational companies with government shareholding to the capital market, aiming to ...

RAPT Therapeutics shares surged after GSK agreed to acquire the biotech for $2.2 billion, adding a promising food allergy ...

GSK plc (NYSE:GSK) is one of the best performing pharma stocks in 2025. Jefferies reaffirmed a Buy rating on GSK plc (NYSE:GSK) on January 7 and set a price target of $55.60. The same day, GSK plc ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The sale price is 60% less than ...

The TTP’s growing attacks in Pakistan from sanctuaries in Afghanistan led to serious frictions with Kabul. Attacks by Baloch insurgents became more audacious in 2025. According to the South Asia ...

A new Reuters report, based on data from healthcare research firm 3 Axis Advisors, names Pfizer (PFE) and GSK (GSK) among the leading drugmakers seeking to hike U.S. prices of as many as 360 branded ...